Drug intelligence / Profile preview

Baifeng Yin

Development stage: Unknown
Lead developer: Kanghui
Administration: Oral

Overview

Baifeng Yin is a Traditional Chinese Medicine (TCM) oral formulation developed and marketed by Shaanxi Kanghui Pharmaceutical. It is primarily indicated for gynecological conditions, specifically those arising from a deficiency in both Qi and blood. The formulation is designed to replenish Qi, nourish blood, regulate menstruation, and address vaginal discharge (leukorrhea). It is commonly used to treat symptoms such as irregular menstruation, physical weakness, emaciation, and soreness in the lower back and knees. As a TCM product, Baifeng Yin utilizes a complex mixture of herbal ingredients that work synergistically to restore physiological balance, rather than targeting a single molecular pathway.

Brand names: Baifeng Yin
Other names: 白凤饮

Beyond the preview

Go deeper on Baifeng Yin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baifeng Yin.

Explore the full profile